measuregroup/AID1805115

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442076394_AID1805115_PMID_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442076395_AID1805115_PMID_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442076393_AID1805115_PMID_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442076394_AID1805115_PMID_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442076395_AID1805115_PMID_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442076393_AID1805115_PMID_VALUE2
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C6X1
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title	Activity of Compound 1A and 1B Against Coronavirus in BHK-21 from US Patent US10874687: \"Highly active compounds against COVID-19\"
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442076395 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442076394 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442076393
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1805115

Total number of triples: 14.